Return on investment (ROI), also called return on invested capital, is the profit a company earns for every dollar of long-term capital from both lenders and shareholders, shown as a percentage. It is net income divided by long-term debt plus shareholder equity, and the table shows both amounts. Because debt is included in the base, ROI does not rise just because a company replaces equity with borrowing, which sets it apart from ROE. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
Bionano Genomics, Inc. roi for the quarter ending 2020-12-31 was -79.96%, a change of 45.86% year-over-year.
Bionano Genomics, Inc. roi for the quarter ending 2020-09-30 was -121.46%.
Bionano Genomics, Inc. roi for the quarter ending 2020-06-30 was -152.59%.
Bionano Genomics, Inc. roi for the quarter ending 2019-12-31 was -125.82%, a change of -29.31% year-over-year.
Bionano Genomics, Inc. roi for fiscal 2020 was -79.96%, a change of 45.85% from fiscal 2019.
Bionano Genomics, Inc. roi for fiscal 2019 was -125.81%, a change of -29.31% from fiscal 2018.
Bionano Genomics, Inc. roi for fiscal 2018 was -96.50%, a 279.65% decline from fiscal 2017.
Bionano Genomics, Inc. roi for fiscal 2017 was 53.72%.